Brief: Bioinvent Achieves Phase 3 Milestone, Eligible For EUR 1 Mln Payment
26/03/2026 14:33
March 26 (Reuters) - BioInvent International AB BINV.ST: ACHIEVES PHASE 3 MILESTONE FOR HMI-115 IN ENDOMETRIOSIS ENTITLED TO EUR 1 MILLION MILESTONE PAYMENT Source text: ID:nMFN3RzD7q Further company coverage: BINV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))